Breaking News Instant updates and real-time market news.

VZ

Verizon

$48.65

0.25 (0.52%)

, PM

Philip Morris

$112.51

-0.14 (-0.12%)

20:25
10/18/17
10/18
20:25
10/18/17
20:25

Notable companies reporting before tomorrow's open

Notable companies reporting before tomorrow's open, with earnings consensus, include Verizon (VZ), consensus 98c... Philip Morris (PM), consensus $1.38... Danaher (DHR), consensus 95c... Bank of New York Mellon (BK), consensus 92c... Blackstone (BX), consensus 55c... BB&T (BBT), consensus 78c... Travelers (TRV), consensus 40c... PPG Industries (PPG), consensus $1.52... Rogers Communications (RCI), consensus 80c... Nucor (NUE), consensus 78c... Dover (DOV), consensus $1.12... Genuine Parts (GPC), consensus $1.29... Textron (TXT), consensus 62c... Quest Diagnostics (DGX), consensus $1.35... Alliance Data Systems (ADS), consensus $5.04.

VZ

Verizon

$48.65

0.25 (0.52%)

PM

Philip Morris

$112.51

-0.14 (-0.12%)

DHR

Danaher

$86.05

0.79 (0.93%)

BK

BNY Mellon

$54.46

0.5 (0.93%)

BX

Blackstone

$33.49

0.27 (0.81%)

BBT

BB&T

$46.54

0.02 (0.04%)

TRV

Travelers

$130.02

1.37 (1.06%)

PPG

PPG

$112.88

-0.08 (-0.07%)

RCI

Rogers Communications

$53.75

-0.23 (-0.43%)

NUE

Nucor

$57.28

0.17 (0.30%)

DOV

Dover

$93.57

-0.48 (-0.51%)

GPC

Genuine Parts

$98.04

1.18 (1.22%)

TXT

Textron

$53.57

0.5 (0.94%)

DGX

Quest Diagnostics

$92.05

-0.13 (-0.14%)

ADS

Alliance Data

$228.38

1.44 (0.63%)

  • 19

    Oct

  • 19

    Oct

  • 19

    Oct

  • 19

    Oct

  • 19

    Oct

  • 19

    Oct

  • 19

    Oct

  • 19

    Oct

  • 19

    Oct

  • 19

    Oct

  • 19

    Oct

  • 19

    Oct

  • 19

    Oct

  • 19

    Oct

  • 19

    Oct

  • 22

    Oct

  • 30

    Oct

  • 01

    Nov

  • 06

    Nov

  • 07

    Nov

  • 13

    Nov

  • 16

    Nov

  • 29

    Nov

  • 30

    Nov

  • 14

    Dec

VZ Verizon
$48.65

0.25 (0.52%)

10/16/17
10/16/17
DOWNGRADE

Perform
Crown Castle downgraded to Perform at Oppenheimer
As previously reported, Oppenheimer analyst Timothy Horan downgraded Crown Castle (CCI) to Perform from Outperform saying that recent reports denote a T-Mobile (TMUS)/Sprint (S) merger is imminent, and as it represents 40% of revenues and will be aggressively slashing supplier spending, which will offset growth in 600 MHz, FirstNet, 5G. The analyst sees a 70% probability of the deal receiving approval with major concessions and likely also attacking the wireline market and better able to compete with Verizon (VZ)/AT&T (T) on coverage/capacity.
09/20/17
OPCO
09/20/17
NO CHANGE
OPCO
Perform
Oppenheimer expects Sprint, T-Mobile merger to happen
Oppenheimer analyst Timothy Horan expect T-Mobile (TMUS) to merge with Sprint (S) in a stock-for-stock transaction at a $10 per share Sprint valuation. A T-Mobile/Sprint will be a better competitor to Verizon (VZ)/AT&T (T), the analyst says, adding that while the process is likely to have a few bumps and require time, he expects a merger to happen. Horan reiterates a Perform rating on Sprint's shares.
09/20/17
DBAB
09/20/17
NO CHANGE
DBAB
Sprint, T-Mobile merger unlikely to get regulatory approval, says Deutsche Bank
Deutsche Bank analyst Matthew Niknam continues to believe a potential merger between Sprint (S) and T-Mobile (TMUS) faces "significant hurdles" and is ultimately unlikely to get past regulatory concerns. Merits of the deal, however, are "unparalleled, and very tough to debate," Niknam tells investors in a research note following CNBC's report of progressing deal talks. He believes derivative stock reactions on the news, namely strength in AT&T (T) and Verizon (VZ) and weakness in the tower names, could be at risk of reversing. Among the towers, the analyst has Buy ratings on American Tower (AMT) and Crown Castle (CCI).
09/05/17
MSCO
09/05/17
NO CHANGE
Target $53
MSCO
Overweight
Morgan Stanley predicts another 5c dividend hike coming for Verizon
Morgan Stanley analyst Simon Flannery said he sees a few arguments for Verizon continuing its recent dividend growth pattern, but he also sees some counter-arguments for a smaller increase or even a dividend freeze. In the end, he expects the company, which has raised its dividend annually since 2007, will hike its annual dividend by 5c this quarter, most likely with an announcement being made this Thursday, September 7. Flannery keeps an Overweight rating and $53 price target on Verizon shares.
PM Philip Morris
$112.51

-0.14 (-0.12%)

10/06/17
WELS
10/06/17
NO CHANGE
WELS
Nicotine study could pressure tobacco stocks, says Wells Fargo
Dr. Dorothy Hatsukami's 1,250 patient, 20 week Phase III study, which suggested an immediate reduction in nicotine levels by the FDA would be more effective than a gradual reduction in terms of discouraging compensatory behavior, could create near-term headline risk for tobacco stocks, Wells Fargo analyst Bonnie Herzog tells investors in an intraday research note after XXII Century Group announced the results. Investors may worry the data could precipitate sharper declines in combustible cigarette volumes, the analyst contends. She continues to believe, however, that such an outcome would only accelerate conversion to reduced-risk products such as iQOS, which she notes does not appear to have been a part of the study. Publicly traded companies in the tobacco space include Altria Group (MO), British American Tobacco (BTI) and Philip Morris (PM).
09/28/17
09/28/17
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. McDonald's (MCD) upgraded to Buy from Neutral at Longbow with analyst Alton Stump citing better than expected third quarter U.S. comparable store sales trends. 2. Philip Morris (PM) upgraded to Conviction Buy from Buy at Goldman Sachs with analyst Judy Hong saying the company offers a "rare innovation product cycle story within Staples" along with the strongest global positioning in next generation products. 3. BlackRock (BLK) upgraded to Conviction Buy from Buy at Goldman Sachs with analyst Alexander Blostein saying he expects an acceleration in annual operating income growth given improving trends in active, easing pressures on blended fee rates, and scaling of its tech platform which should lead to sustainable multiple improvement. 4. Potbelly (PBPB) upgraded to Overweight from Neutral at Piper Jaffray with analyst Nicole Miller Regan saying she believes a "compelling" turnaround is building. 5. Huntsman (HUN) upgraded to Outperform from Market Perform at Wells Fargo with analyst Frank Mitsch saying the recent weakness in the shares is a buying opportunity. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
09/28/17
GSCO
09/28/17
UPGRADE
Target $135
GSCO
Conviction Buy
Philip Morris upgraded to Conviction Buy from Buy at Goldman Sachs
Goldman Sachs analyst Judy Hong upgraded Philip Morris (PM) to Conviction Buy and reiterates the stock as her top pick in within tobacco. The company offers a "rare innovation product cycle story within Staples" along with the strongest global positioning in next generation products, Hong tells investors in a research note where she also upgraded Brown-Forman (BF.B) to Neutral. The analyst views Philip Morris' IQOS as a "game-changer for Global Tobacco." She raised her price target for the shares to $135 from $133. Hong also highlights Mondelez (MDLZ), Estee Lauder (EL) and Kimberly-Clark (KMB) as top multinational picks.
10/10/17
WELS
10/10/17
NO CHANGE
Target $140
WELS
Outperform
Philip Morris recent stock pullback overdone, says Wells Fargo
Wells Fargo analyst Bonnie Herzog says that the recent Phillip Morris stock pullback is overdone, making risk/reward look more favorable. The analyst recommends buying ahead of Q3 results as she expects strong iQOS performance, resilience in key combustible cigarette markets, and the continued success of its premiumization strategy. Herzog reiterates an Outperform rating and $140 price target on the shares.
DHR Danaher
$86.05

0.79 (0.93%)

09/26/17
GSCO
09/26/17
INITIATION
Target $83
GSCO
Neutral
Danaher assumed with a Neutral at Goldman Sachs
Goldman analyst Patrick Donnelly assumed coverage on Danaher with a Neutral and $83 price target saying exposure to more challenging markets, particularly dental, present headwinds and will continue to drive below industry organic growth.
09/08/17
JPMS
09/08/17
NO CHANGE
Target $95
JPMS
Overweight
Danaher added to Analyst Focus List at JPMorgan
JPMorgan analyst Tycho Peterson added Danaher to his firm's Analyst Focus List saying the risk/reward looks attractive at current valuation levels. Organic growth likely bottomed out in Q2, second half targets look achievable and investor sentiment "feels largely washed out," Peterson tells investors in a research note. He reiterates an Overweight rating on the shares with a $95 price target.
07/13/17
07/13/17
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. HP Inc. (HPQ), 3D Systems (DDD), and Stratasys (SSYS) were initiated with a Neutral at Susquehanna. 2. Danaher (DHR) initiated with a Market Perform at Wells Fargo. 3. E-Trade (ETFC) and TD Ameritrade (AMTD) were initiated with a Buy at Rosenblatt, while Charles Schwab (SCHW) was initiated with a Neutral. 4. C&J Energy Services (CJ) initiated with a Buy at Jefferies. 5. BIO-key (BKYI) initiated with a Buy at Maxim. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
07/13/17
WELS
07/13/17
INITIATION
WELS
Market Perform
Danaher initiated at Wells Fargo
As noted earlier, Wells Fargo analyst Tim Evans started coverage of Danaher with a $90 price target and a Market Perform rating. Evans says that the company's acquisition of Cepheid indicates that it is focusing on clinical diagnostics markets, and he is cautious about that space. Additionally, he believes that some are overestimating the company's potential for revenue acceleration, and he says that its recent deals have been expensive.
BK BNY Mellon
$54.46

0.5 (0.93%)

05/26/17
BOFA
05/26/17
INITIATION
Target $49
BOFA
Underperform
BNY Mellon reinstated with an Underperform at BofA/Merrill
BofA/Merrill analyst Michael Carrier reinstated coverage on BNY Mellon with an Underperform and a $49 price target given low revenue growth outlook.
10/13/17
GSCO
10/13/17
NO CHANGE
GSCO
McDonald's 'can outperform for several more years,' says Goldman Sachs
Goldman Sachs analyst Karen Holthouse says historical analysis indicates that McDonald's (MCD) can continue to outperform and gain market share at the expense of regional competitors. According to the analyst, after fast food companies underperform for three quarters, they go on to underperform for an average of 4.6 years. Seven of McDonald's "key competitors...are relatively early in these cycles of underperformance," the analyst wrote. However, Holthouse believes that the risk to Wendy's (WEN) and Restaurant Brands' (QSR) Burger King from McDonald's rebound "may be overstated," since Burger King and Wendy's would only have to gain 30 basis points of share from other fast food players to offset a 5% comp sales gain by McDonald's, according to the analyst. The analyst trimmed her price target on McDonald's to $172 from $174, citing a "modeling error." She cut her price target on Bojangles (BOJA) to $12.50 from $14.50 and lowered her fiscal 2018 comp sales estimates for Bojangles, Dunkin' Brands (DNKN), and Restaurant Brands, citing the latter company's ownership of Popeye's. She sees Bojangle's, Jack in the Box (JACK), and Dunkin Brands as having the most risk, in order from greatest to least, from McDonald's resurgence.
09/08/17
UBSW
09/08/17
DOWNGRADE
UBSW
Neutral
BNY Mellon downgraded to Neutral from Buy at UBS
08/09/17
WELS
08/09/17
INITIATION
Target $55
WELS
Market Perform
BNY Mellon initiated with a Market Perform at Wells Fargo
Wells Fargo analyst Mike Mayo started BNY Mellon with a Market Perform rating and $55 price target.
BX Blackstone
$33.49

0.27 (0.81%)

05/22/17
JMPS
05/22/17
NO CHANGE
JMPS
Blackstone deal with Saudi Arabia positive, says JMP Securities
JMP Securities analyst Devin Ryan says that the new infrastructure investment vehicle that Blackstone launched with the Public Investment Fund of Saudi Arabia may boost the shareholder value of Blackstone by over 10%. The analyst adds that the deal shows that Blackstone "can evolve and innovate," which makes its growth outlook "strong." He keeps a $38 price target and Outperform rating on the shares.
05/22/17
05/22/17
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Qualcomm (QCOM) upgraded to Overweight from Neutral at JPMorgan with analyst Rod Hall saying while more negative news from the Apple (AAPL) royalty suit is likely, "material fundamental upside" exists from the closure of the NXP Semiconductors (NXPI) by the end of this year. The analyst views the deal as highly accretive. Hall also believes Apple ultimately will want to preserve its commercial relationship with Qualcomm. 2. Motorola Solutions (MSI) upgraded to Outperform from Market Perform at Raymond James with analyst Tavis McCourt saying shares look increasingly attractive based on improved demand visibility that is less economically sensitive than many of its peers, and demand catalysts from FirstNet buildouts that are expected to start in 2018. 3. Entegris (ENTG) upgraded to Conviction Buy from Buy at Goldman Sachs with analyst Toshiya Hari citing the recent pullback in shares and maintained a $29 price target. 4. Blackstone (BX) upgraded to Buy from Neutral at Citi with analyst William Katz saying the company's intentions to raise a $40B infrastructure fund should be a "valuation catalyst." 5. Cree (CREE) upgraded to Outperform from Market Perform at JMP Securities with analyst Joseph Osha saying he thinks that the company's new CEO could make positive changes at the company. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
05/22/17
SBSH
05/22/17
UPGRADE
Target $40
SBSH
Buy
Blackstone upgraded to Buy from Neutral at Citi
Citi analyst William Katz upgraded Blackstone Group to Buy and raised his price target for the shares to $40 from $32. The company's intentions to raise a $40B infrastructure fund should be a "valuation catalyst," the analyst contends.
09/18/17
FBCO
09/18/17
NO CHANGE
FBCO
Blackstone Vivint IPO/sale potential positive for Alarm.com, says Credit Suisse
Credit Suisse analyst Michael Nemeroff notes that several news outlets disclosed that Blackstone (BX) is running a process that could lead to an IPO or sale of Vivint, a smart-home technology company. The analyst believes that the IPO or sale of Vivint could have positive implications for Alarm.com (ALRM). An IPO could validate the market for connected home security products and promote awareness in a market where Alarm.com holds the dominant leadership position, while a sale could result in business disruptions at Vivint, which could allow Alarm.com to further extend its lead in the market, Nemeroff contends.
BBT BB&T
$46.54

0.02 (0.04%)

08/09/17
WELS
08/09/17
INITIATION
Target $44
WELS
Market Perform
BB&T resumed with a Market Perform at Wells Fargo
Wells Fargo analyst Mike Mayo resumed coverage of BB&T with a Market Perform rating and $44 price target.
08/04/17
MACQ
08/04/17
UPGRADE
Target $47
MACQ
Neutral
BB&T upgraded to Neutral from Underperform at Macquarie
Macquarie analyst David Konrad upgraded BB&T to Neutral with a $47 price target saying valuation is more reasonable following relative underperformance and operating leverage continues to improve.
10/05/17
10/05/17
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Microsoft (MSFT) upgraded to Buy from Hold at Canaccord with analyst Richard Davis saying investors are underestimating the "virtuous cycles" of Microsoft's four "compelling" growth drivers, namely Office Productivity, Gaming, Marketing, and Azure's Platform as a Service. 2. Biogen (BIIB) upgraded to Overweight from Equal Weight at Morgan Stanley with analyst Matthew Harrison saying the base business is underappreciated and Ocrevus share loss is slower than expected. 3. Sherwin-Williams (SHW) upgraded to Buy from Underperform at BofA/Merrill with analyst Steve Byrne saying the company announced a 3%-5% price increase on Tuesday and detailed plans to expand PF EBITDA margin to 19%-21% in 2020 from 17% in 2016. 4. BB&T (BBT) upgraded to Overweight from Equal Weight at Stephens with analyst Terry McEvoy noting that it has been the worst performing Super Regional bank in 2017 and he recommends taking advantage of that underperformance as he expects it to produce among the highest returns in the group going forward. 5. Celsion (CLSN) upgraded on improved financial outlook at Maxim with analyst Jason McCarthy saying the changes to the company's agreement with warrant holders, enabling the warrants to be exercised immediately following a rally in the stock, have removed the financial overhang on the company. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
10/05/17
SPHN
10/05/17
UPGRADE
Target $53
SPHN
Overweight
BB&T upgraded to Overweight from Equal Weight at Stephens
Stephens analyst Terry McEvoy upgraded BB&T to Overweight from Equal Weight, noting that it has been the worst performing Super Regional bank in 2017 and he recommends taking advantage of that underperformance as he expects it to produce among the highest returns in the group going forward. The analyst, who has confidence on BB&T's Q3 trends following the bank's update at a conference last month, set a $53 price target on the shares.
TRV Travelers
$130.02

1.37 (1.06%)

09/11/17
LEHM
09/11/17
NO CHANGE
LEHM
Irma and Harvey insured losses expected to top $100B, says Barclays
Barclays analyst Jay Gelb notes initial indications are Hurricane Irma's impact on Florida could result in insured losses of up to $60B. Irma will likely be the largest storm to ever impact the U.S., although not as bad as if Miami suffered a direct hit, Gelb tells investors in a research note on the insurance space titled "Devastating Irma Impact on Insurers, But It Could Have Been Worse." All in, Irma and Harvey insured losses are expected to exceed $100B, Gelb points out. He believes the re/insurance stocks could suffer from near-term uncertainty regarding the extent of losses. Of the names he covers, the analyst expects Everest Re (RE), XL Group (XL), RenaissanceRe (RNR), Validus (VR) and Aspen Insurance (AHL) "to take the brunt of Irma losses." Book value declines of more than 20% could require equity capital raises, Gelb contends. He says Chubb (CB), Travelers (TRV) and Hartford Financial (HIG) have relatively less exposure while AIG (AIG) could have greater losses among the primary insurers.
09/11/17
BUCK
09/11/17
INITIATION
Target $136
BUCK
Buy
Travelers initiated with a Buy at Buckingham
Buckingham analyst Amit Kumar initiated Travelers with a Buy and a $136 price target.
09/11/17
JPMS
09/11/17
NO CHANGE
JPMS
Irma losses could be lower than expected, says JPMorgan
JPMorgan analyst Sarah DeWitt believes losses from Hurricane Irma could be at the lower end of the $20B-$60B expected range since the storm weakened faster than expected. The analyst estimates the impact to book values for the companies she covers should be a "manageable" 1%-2%. Among the property casualty insurers, the analyst views Validus (VR), Everest Re (RE) and XL Group (XL) as the most oversold. She lists those three along with RenaissanceRe (RNR), Travelers (TRV), Arch Capital (ACGL), Chubb (CB), Allstate (ALL) and Progressive (PGR) as the P&C insurers with the most exposure to U.S. hurricanes.
10/16/17
KBWI
10/16/17
UPGRADE
KBWI
Outperform
Travelers upgraded to Outperform from Market Perform at Keefe Bruyette
Keefe Bruyette analyst Meyer Shields upgraded Travelers to Outperform citing expectations for personal auto margin expansion and core commercial loss ratio stability.
PPG PPG
$112.88

-0.08 (-0.07%)

07/24/17
RHCO
07/24/17
DOWNGRADE
RHCO
Hold
PPG downgraded on growth ,margin outlook at SunTrust
As noted earlier, SunTrust downgraded PPG to Hold from Buy. Following the company's Q2 results, analyst James Sheehan predicts that the company's EPS will increase just 4% this year due to input cost pressure and low coatings demand. He expects the stock to "remain range-bound" until the company's revenue and/or margins rebound.
07/24/17
07/24/17
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Goldman Sachs (GS) downgraded to Neutral from Buy at UBS with analyst Brennan Hawken saying the market seems to be pricing in an inflection in Goldman's trading revenue despite the recent weakness, suggesting a recovery is needed to justify 2018 consensus estimates. 2. Constellation Brands (STZ) downgraded to Neutral from Conviction Buy at Goldman Sachs. 3. Boston Beer (SAM) downgraded to Sell from Neutral at Goldman Sachs with analyst Judy Hong saying she sees further downside risk from weaker volumes and believes 2018 will be another year of volume decline and limited margin offset. 4. athenahealth (ATHN) downgraded to Underweight from Equal-Weight at First Analysis with analyst Frank Sparacino saying the valuation at current share levels is ahead of the underlying fundamentals in the short term. 5. PPG (PPG) was downgraded to Hold from Buy at SunTrust and to Neutral from Buy at BofA/Merrill. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
07/24/17
JPMS
07/24/17
INITIATION
Target $365
JPMS
Neutral
Sherwin-Williams reinstated with a Neutral at JPMorgan
JPMorgan analyst Jeffrey Zekauskas reinstated coverage of Sherwin-Williams (SHW) with a Neutral rating and $365 price target. The anlayst prefers PPG (PPG) for its valuation.
07/24/17
BOFA
07/24/17
DOWNGRADE
Target $115
BOFA
Neutral
PPG downgraded to Neutral from Buy at BofA/Merrill
BofA/Merrill analyst Steve Byrne downgraded PPG to neutral and retained its $115 price target citing sluggish fundamentals and limited near-term catalysts and sees better relative value elsewhere in the group. The analyst said Q2 organic growth was zero and is concerned about the impact from a deceleration in global auto production and said PPG's ability to pass through rising raw material costs is unclear.
RCI Rogers Communications
$53.75

-0.23 (-0.43%)

04/19/17
ADAM
04/19/17
NO CHANGE
ADAM
Buy
Rogers Communications price target raised to C$66 from C$60 at Canaccord
Canaccord analyst Aravinda Galappatthige raised his price target on Rogers Communications to C$66 from C$60 following its strong Q1 results. The analyst noted the strength was led by its wireless sector, which had EBITDA growth, postpaid net adds, wireless ARPU, and strong revenue growth. Galappatthige reiterated his Buy rating on Rogers Communications shares based on improving fundamentals.
01/26/17
ADAM
01/26/17
UPGRADE
ADAM
Buy
Rogers Communications upgraded to Buy from Hold at Canaccord
01/27/17
ADAM
01/27/17
UPGRADE
ADAM
Buy
Rogers Communications upgraded to Buy at Canaccord
As previously reported, Canaccord analyst Aravinda Galappatthige upgraded Rogers Communications to Buy from Hold following strong Q4 results. The analyst cited the positive outlook for the wireless sector and expectations for stronger free cash flow growth after 2017. Galappatthige raised his price target to C$60 from C$58 on Rogers Communications shares.
04/05/17
CIBC
04/05/17
DOWNGRADE
CIBC
Neutral
Rogers Communications downgraded to Neutral on valuation at CIBC
CIBC analyst Robert Bek downgraded Rogers Communications to Neutral from Outperform citing valuation.
NUE Nucor
$57.28

0.17 (0.30%)

09/15/17
SBSH
09/15/17
NO CHANGE
Target $65
SBSH
Buy
Citi says now time to buy shares of Nucor
Citi analyst Alexander Hacking attributes Nucor's weaker Q3 guidance to higher scrap prices, weaker plate demand and the DRI outage in Louisiana. The miss was widely anticipated and the stock is trading down less than 1%, Hacking tells investors in a research note. The analyst feels now is the time to buy the stock. He keeps a Buy rating on Nucor with a $65 price target.
10/02/17
LBOW
10/02/17
DOWNGRADE
LBOW
Neutral
Nucor downgraded to Neutral from Buy at Longbow
09/28/17
FBCO
09/28/17
NO CHANGE
Target $63
FBCO
Outperform
Nucor price target lowered to $63 from $68 at Credit Suisse
Credit Suisse analyst Curt Woodworth lowered his price target for Nucor to $63 from $68 to account for reduced EBITDA estimates on the account of weakness in rebar and plate metal spreads. The analyst reiterates an Outperform rating on the shares.
10/02/17
LBOW
10/02/17
DOWNGRADE
LBOW
Neutral
Nucor downgraded to Neutral on survey weakness at Longbow
As previously reported, Longbow downgraded Nucor to Neutral from Buy. Analyst Chris Olin cut Q4 and 2018 estimates across the steel sector following carbon steel channel checks that indicate incremental demand weakness. Olin said order activity slowed considerably since summer and industry contacts recently lowered near-term pricing expectations on HRC despite reduced import availability. The analyst said there is risk of metal spread contraction over the next two quarters and Nucor shares could see selling pressure if management talks down Q4 outlook later this month.
DOV Dover
$93.57

-0.48 (-0.51%)

06/08/17
BMOC
06/08/17
UPGRADE
BMOC
Outperform
Dover upgraded on increased earnings diversification outlook at BMO Capital
As noted earlier, BMO Capital upgraded Dover to Outperform from Market Perform. Analyst R. Scott Graham thinks that the proportion of overall operating income generated by the company's Energy unit will drop to 30% by mid 2018 from about 80% in 1H17. The analyst says that the change will lower the risk posed by the stock and increasingly prevent the shares from being moved by oil price fluctuations. Target to $94 from $89.
06/21/17
GHSC
06/21/17
DOWNGRADE
Target $86
GHSC
Neutral
Dover downgraded to Neutral from Buy at Seaport Global
Seaport Global analyst Ryan Cassil downgraded Dover to Neutral and cut its price target to $86 from $91 to reflect a new commodity price deck. Seaport Global's Energy team reduced its long-term oil forecast to $40/bbl from $50/bbl to reflect "relentless" US production growth. The firm sees the potential for the oil market to be "significantly over supplied in 2018 and cut its oil price forecast for first half 2017 to $45/bbl from $55/bbl and first half 2018 to $35/bbl from $55/bbl.
09/20/17
JPMS
09/20/17
UPGRADE
JPMS
Overweight
Dover upgraded to Overweight from Neutral at JPMorgan
JPMorgan analyst C. Stephen Tusa upgraded Dover to Overweight and raised his price target for the shares to $105 from $80. The analyst sees the shares continuing to rally on relative organic outperformance and, over time, further capital deployment.
10/12/17
RHCO
10/12/17
NO CHANGE
RHCO
Diversified Industrials sector to show stronger Q3 organic growth, says SunTrust
SunTrust analyst Charles Brady previewed Q3 earnings for Diversified Industrials, forecasting acceleration of organic growth reflecting improved demand. He says there is visible growth across most regions and end markets, maintaining a favorable view on U.S. construction, defense, and municipal spending, with an added upside opportunity from agriculture, mining, and water. Among the companies with the biggest potential, he expects Nordson (NDSN) to recover from recent order weakness, Oshkosh (OSK) to benefit from faster recovery in access equipment, and Rexnord (RXN) to see strong growth in Process & Motion Control division. Brady is also raising his price targets on A.O. Smith (AOS) to $65 from $60, Dover (DOV) to $90 from $88, Fortive (FTV) to $77 from $70, and Generac (GNRC) to $47 from $38. Among those, he sees Fortive's recent acquisitions driving top-line growth and for Generac to show higher activity in generators in the wake of recent hurricanes.
GPC Genuine Parts
$98.04

1.18 (1.22%)

09/25/17
RBCM
09/25/17
NO CHANGE
RBCM
Genuine Parts acquisition of Alliance makes strategic sense, says RBC
RBC Capital analyst Scot Ciccarelli maintained a Sector Perform rating on Genuine Parts, saying that while the company's agreement to acquire Alliance Automotive Group for $2.0B makes strategic sense, Genuine Parts' high valuation relative to its organic earnings leaves Ciccarelli "on the sidelines." RBC did, however, raise its price target on Genuine Parts to $98 from $85 after the acquisition announcement.
07/06/17
GSCO
07/06/17
DOWNGRADE
Target $89
GSCO
Sell
Genuine Parts downgraded to Sell from Neutral at Goldman Sachs
Goldman analyst Matthew Fassler downgraded Genuine Parts (GPC) to Sell from Neutral citing relative valuation and reduced forecasts and cut its price target to $89 from $104 to reflect the O'Reilly (ORLY) Q2 pre-announcement.
07/21/17
GABE
07/21/17
UPGRADE
GABE
Buy
Genuine Parts upgraded to Buy from Hold at Gabelli
Gabelli analyst Brian Sponheimer upgraded Genuine Parts to Buy with a $101 price target citing the pullback in shares.
09/15/17
09/15/17
NO CHANGE

Wolfe calls it 'way too early' to think about LBOs for most auto part
Wolfe Research analyst Chris Bottiglieri noted that auto part retailers have been "spookily rebounding" despite his survey pointing to negative investor sentiment, leading him to revisit his LBO model to assess take-out risk for the group. He concludes that while Advance Auto Parts (AAP) is entering a valuation range where an LBO is "in the discussion," he sees it as still "way too early" to consider the possibility of an LBO for O'Reilly Automotive (ORLY), AutoZone (AZO) or Genuine Parts (GPC). While Advance Auto shareholder Starboard may not sanction a deal that locks in losses, his estimated holding cost of $154 for the firm is a "soft floor" for a take-out price, he added.
TXT Textron
$53.57

0.5 (0.94%)

09/11/17
DRXL
09/11/17
UPGRADE
DRXL
Buy
Textron upgraded to Buy from Hold at Drexel Hamilton
07/21/17
BOFA
07/21/17
DOWNGRADE
Target $45
BOFA
Underperform
Textron downgraded to Underperform from Buy at BofA/Merrill
BofA/Merrill downgraded Textron two notches to Underperform from Buy and cut its price target to $45 from $53. Analyst Ronald Epstein said medium term organic growth is being pressured by end market weakness in business jets, helicopters, and industrial products. The analyst lowered his 2018 earnings estimate to $2.80 from $2.95, 2019 to $3.15 from $3.35, 2020 to $3.45 from $3.70, and 2021 to $3.80 from $4.10.
07/20/17
FBCO
07/20/17
NO CHANGE
Target $55
FBCO
Outperform
Textron price target raised to $55 from $50 at Credit Suisse
Credit Suisse analyst Julian Mitchell raised his price target for Textron to $55 from $50 following Q2 results. The analyst reiterates an Outperform rating on the shares.
10/09/17
RBCM
10/09/17
NO CHANGE
Target $209
RBCM
Outperform
Defense and Aerospace sector poised for strong Q3, says RBC Capital
RBC Capital analyst Matthew McConnell previewed the Q3 earnings season for the defense and commercial aviation industries, raising price targets across the sectors. In defense, McConnell likes the companies with focus on international markets, where demand has not yet been reflected in orders or backlog. Among his favorites, McConnell raises the price target on Raytheon (RTN) to $209 from $193, General Dynamics (GD) to $241 from $220, Northrop Grumman (NOC) to $324 from $294, Lockheed Martin (LMT) to $327 from $289, and Triumph (TGI) to $38 from $33. He also states that there may be room for some consolidation in defense given that budget up-cycle is only 2 years old, profiling Astronics (ATRO), Barnes (B), Esterline (ESL), Heico (HEI), and Textron (TXT) as some of the potential targets. In commercial aviation, McConnell sees Boeing (BA) upside driven by continued strong air traffic growth, mature sales campaigns, and expectations for a strong wide-body replacement cycle starting in the early 2020s, raising his price target on Boeing to $269 from $235.
DGX Quest Diagnostics
$92.05

-0.13 (-0.14%)

10/10/17
10/10/17
DOWNGRADE
Target $113

Buy
Quest Diagnostics removed from Conviction Buy List at Goldman Sachs
As previously reported, Goldman removed Quest Diagnostics from the Conviction Buy List and lowered its price target to $113 from $121. Analyst Isaac Ro thinks share gains associated with PAMA reimbursement cuts could take time to manifest as competitors debate long-term strategies. The analyst maintains a Buy rating on Quest given its a pure-play on lab testing, margin expansion opportunities, and shareholder friendly capital deployment.
10/12/17
WELS
10/12/17
UPGRADE
Target $175
WELS
Outperform
LabCorp resumed with an Outperform from Market Perform at Wells Fargo
Wells Fargo analyst Tim Evans resumed coverage of LabCorp and upgraded the shares to Outperform with a $175 price target. The analyst sees LabCorp outperforming Quest Diagnostics (DGX) due to its "slightly" higher revenue growth profile and diversification as well as more attractive valuation.
10/17/17
CHLM
10/17/17
NO CHANGE
Target $100
CHLM
Hold
Quest Diagnostics price target lowered to $100 from $110 at Craig-Hallum
Craig-Hallum analyst Kevin Ellich lowered his price target for Quest Diagnostics to $100 from $110 to account for hurricane-related disruption in Florida, Texas, and Puerto Rico based on its disclosure in late September. The analyst views the weather-related impact as a one-time event. He reiterates a Hold rating on the shares.
10/12/17
WELS
10/12/17
INITIATION
Target $88
WELS
Market Perform
Quest Diagnostics resumed with a Market Perform at Wells Fargo
Wells Fargo analyst Tim Evans resumed coverage of Quest Diagnostics with a Market Perform rating and $88 price target. The rating is unchanged from his firm's prior coverage.
ADS Alliance Data
$228.38

1.44 (0.63%)

07/21/17
JMPS
07/21/17
NO CHANGE
JMPS
Alliance Data weakness 'excessive,' says JMP Securities
After Alliance Data lowered its fiscal 2017 EPS guidance, partly due to delayed recoveries and uncollectible finance charges, JMP Securities analyst David Scharf says that demand for the company's card and non-credit businesses.remains strong. He thinks that the company's earnings outlook remains strong, and he calls the decline in the company's stock "excessive." He keeps a $285 price target and an Outperform rating on the shares.
07/21/17
LEHM
07/21/17
DOWNGRADE
Target $265
LEHM
Equal Weight
Alliance Data downgraded to Equal Weight from Overweight at Barclays
Barclays analyst Darrin Peller downgraded Alliance Data Systems to Equal Weight and lowered his price target for the shares to $265 from $285. Secular headwinds to the overall retail environment and credit "normalization" will weigh on the valuation in the near term, Peller tells investors in post-earnings research note. The analyst sees shares as being range-bound pending greater visibility into these factors.
07/13/17
ARGS
07/13/17
INITIATION
ARGS
Buy
Alliance Data initiated with a Buy at Argus
Argus analysts Stephen Biggar and Mike Jaffe started coverage of Allinace Data Systems with a $309 price target and a Buy rating. The analysts say that the company's "private-label and co-branded credit card business is largely insulated from the shift to e-commerce," and they expect it to "post solid operating results in the coming years."
06/07/17
WELS
06/07/17
NO CHANGE
WELS
Alliance Data transaction positive, says Wells Fargo
Wells Fargo believes that Alliance Data's recent acquisition of $1B of receivables from Signet Jewelers gives the company "an attractive source of new business." It thinks that the deal could boost the company's EPS by 84c by 2020. while boosting investor sentiment towards the name. Wells keeps an Outperform rating on the stock.

TODAY'S FREE FLY STORIES

KBR

KBR

$19.19

0.3402 (1.80%)

, FLR

Fluor

$47.67

0.11 (0.23%)

09:55
11/22/17
11/22
09:55
11/22/17
09:55
Periodicals
KBR takeover potential speculation floated by blog »

Shares of KBR (KBR) are…

KBR

KBR

$19.19

0.3402 (1.80%)

FLR

Fluor

$47.67

0.11 (0.23%)

APO

Apollo Global

$30.27

0.1094 (0.36%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Nov

SIG

Signet Jewelers

$54.48

1.69 (3.20%)

, FTR

Frontier Communications

$7.08

-0.15 (-2.07%)

09:55
11/22/17
11/22
09:55
11/22/17
09:55
Options
Early notable gainers among liquid option names on November 22nd »

Notable gainers among…

SIG

Signet Jewelers

$54.48

1.69 (3.20%)

FTR

Frontier Communications

$7.08

-0.15 (-2.07%)

BBBY

Bed Bath & Beyond

$20.27

-0.59 (-2.83%)

RRC

Range Resources

$17.56

0.38 (2.21%)

M

Macy's

$20.63

0.2113 (1.03%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Dec

  • 08

    Dec

  • 20

    Dec

  • 18

    Mar

09:55
11/22/17
11/22
09:55
11/22/17
09:55
General news
FX Action: USD-JPY »

FX Action: USD-JPY has…

T

AT&T

$34.25

-0.08 (-0.23%)

, TWX

Time Warner

$89.74

0.18 (0.20%)

09:53
11/22/17
11/22
09:53
11/22/17
09:53
Conference/Events
FBN Securities strategist to hold an analyst/industry conference call »

FBN Securities…

T

AT&T

$34.25

-0.08 (-0.23%)

TWX

Time Warner

$89.74

0.18 (0.20%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Nov

CUB

Cubic

$62.00

1.25 (2.06%)

09:52
11/22/17
11/22
09:52
11/22/17
09:52
Technical Analysis
Technical View: Cubic up on mobile ticketing contract win for Rhein-Sieg area »

The stock was last up…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Nov

SAN

Banco Santander

$6.49

0.09 (1.41%)

09:50
11/22/17
11/22
09:50
11/22/17
09:50
Options
Santander Mar 7 calls active at the opening bell Wednesday »

Santander Mar 7 calls…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

XXII

22nd Century

$2.31

-0.0094 (-0.41%)

09:46
11/22/17
11/22
09:46
11/22/17
09:46
Hot Stocks
22nd Century to discontinue U.S. sales of RED SUN brand cigarettes »

22nd Century Group…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

09:45
11/22/17
11/22
09:45
11/22/17
09:45
General news
Consumer Sentiment Index to be reported at 10:00 »

Consumer Sentiment Index…

SAN

Banco Santander

, GME

GameStop

09:40
11/22/17
11/22
09:40
11/22/17
09:40
Options
Unusually active option classes on open November 22nd »

Unusual total active…

SAN

Banco Santander

GME

GameStop

HPE

HP Enterprise

HPQ

HP Inc.

CRM

Salesforce

SWKS

Skyworks

$110.25

0.46 (0.42%)

LRCX

Lam Research

$218.91

3.81 (1.77%)

SBUX

Starbucks

$57.26

0.45 (0.79%)

BIDU

Baidu

$244.30

5.76 (2.41%)

AMAT

Applied Materials

$58.80

1.18 (2.05%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Nov

  • 27

    Nov

  • 28

    Nov

  • 28

    Nov

  • 29

    Nov

  • 11

    Dec

  • 25

    Jan

XLE

Energy Select Sector SPDR

09:40
11/22/17
11/22
09:40
11/22/17
09:40
Technical Analysis
Technical View: Energy Select Sector SPDR leads index on the upside »

The Energy Select Sector…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LOW

Lowe's

, HD

Home Depot

09:37
11/22/17
11/22
09:37
11/22/17
09:37
Recommendations
Lowe's, Home Depot analyst commentary  »

Lowe's price target…

LOW

Lowe's

HD

Home Depot

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Feb

09:35
11/22/17
11/22
09:35
11/22/17
09:35
General news
U. Michigan sentiment preview: »

U. Michigan sentiment…

CHFS

CHF Solutions

$7.88

-0.24 (-2.96%)

09:31
11/22/17
11/22
09:31
11/22/17
09:31
Syndicate
CHF Solutions announces $18M public offering »

CHF Solutions announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MTL

Mechel

09:31
11/22/17
11/22
09:31
11/22/17
09:31
Hot Stocks
Mechel announces reversal of Court decision »

Mechel reports a court…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

09:30
11/22/17
11/22
09:30
11/22/17
09:30
General news
The U.S. durables report undershot estimates »

The U.S. durables report…

09:30
11/22/17
11/22
09:30
11/22/17
09:30
General news
Breaking General news story  »

Week of 11/19 Bloomberg…

SNPS

Synopsys

$89.38

0.48 (0.54%)

09:29
11/22/17
11/22
09:29
11/22/17
09:29
Recommendations
Synopsys analyst commentary  »

Synopsys price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AQUA

Evoqua Water

09:26
11/22/17
11/22
09:26
11/22/17
09:26
Hot Stocks
Evoqua Water names Dan Brailer head of investor relations »

Evoqua Water announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ROK

Rockwell Automation

, EMR

Emerson

09:26
11/22/17
11/22
09:26
11/22/17
09:26
Recommendations
Rockwell Automation, Emerson analyst commentary  »

Latest Rockwell rebuff…

ROK

Rockwell Automation

EMR

Emerson

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

09:25
11/22/17
11/22
09:25
11/22/17
09:25
General news
Fed funds futures are slightly firmer toward the back end of the curve »

Fed funds futures are…

PBYI

Puma Biotechnology

$104.90

0.85 (0.82%)

09:24
11/22/17
11/22
09:24
11/22/17
09:24
Hot Stocks
Puma Biotechnology, Specialised Therapeutics Asia enter licensing agreement »

Puma Biotechnology and…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HPE

HP Enterprise

09:22
11/22/17
11/22
09:22
11/22/17
09:22
Hot Stocks
Whitman 'definitively' says not running for President or any other office »

Meg Whitman, speaking in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Nov

  • 11

    Dec

PG

Procter & Gamble

09:22
11/22/17
11/22
09:22
11/22/17
09:22
Hot Stocks
Trian comments on Procter & Gamble's contest to voting tabulation »

Trian Fund Management,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DE

Deere

, SFL

Ship Finance

09:22
11/22/17
11/22
09:22
11/22/17
09:22
Hot Stocks
On The Fly: Pre-market Movers »

UP AFTER EARNINGS: Deere…

DE

Deere

SFL

Ship Finance

EMR

Emerson

ROK

Rockwell Automation

FRO

Frontline

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Nov

  • 22

    Nov

  • 28

    Nov

SIG

Signet Jewelers

09:22
11/22/17
11/22
09:22
11/22/17
09:22
Recommendations
Signet Jewelers analyst commentary  »

Signet Jewelers price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Dec

  • 08

    Dec

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.